<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id><journal-title-group>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2026.1768794</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Systematic Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhang</surname><given-names>Jingyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role></contrib>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Siyu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Jiayao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2767253/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yuqian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role></contrib>
<contrib contrib-type="author"><name><surname>Ni</surname><given-names>Ming</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role></contrib>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Cheng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Huang</surname><given-names>Songqun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Guo</surname><given-names>Zhifu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3318623/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Cardiology, Changhai Hospital, Naval Medical University</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Nursing, Air Force Medical University</institution>, <city>Xi&#x0027;an</city>, <state>Shaanxi</state>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Zhifu Guo <email xlink:href="mailto:guozhifu@126.com">guozhifu@126.com</email> Songqun Huang <email xlink:href="mailto:hsq8593@163.com">hsq8593@163.com</email></corresp>
<fn fn-type="equal" id="an1"><label>&#x2020;</label><p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-11"><day>11</day><month>02</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>13</volume><elocation-id>1768794</elocation-id>
<history>
<date date-type="received"><day>22</day><month>12</month><year>2025</year></date>
<date date-type="rev-recd"><day>16</day><month>01</month><year>2026</year></date>
<date date-type="accepted"><day>19</day><month>01</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Zhang, Liu, Li, Wang, Ni, Jiang, Huang and Guo.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Zhang, Liu, Li, Wang, Ni, Jiang, Huang and Guo</copyright-holder><license><ali:license_ref start_date="2026-02-11">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>This study aims to explore potential risk factors for atrial fibrillation (AF) following lung cancer surgery through a meta-analysis.</p>
</sec><sec><title>Methods</title>
<p>PubMed, Embase, and the Cochrane Library databases were searched to identify all relevant studies on postoperative AF following lung cancer surgery. Inclusion criteria specified adult patients with lung cancer surgery who had clearly reported risk factors for AF. The search was conducted up to October 20, 2025. The quality of included studies was assessed using the standardized NOS scoring tool, and statistical analysis was performed using Stata 15. Data from all included studies were analyzed using a random-effects model.</p>
</sec><sec><title>Results</title>
<p>A total of 13 articles involving 20,701 lung cancer patients were included. The meta-analysis results suggest that age &#x003E;65[OR&#x2009;&#x003D;&#x2009;1.68, 95&#x0025; CI (1.30, 2.16)], Postoperative high BNP [OR&#x2009;&#x003D;&#x2009;3.82, 95&#x0025; CI (1.43, 10.25)], male [OR&#x2009;&#x003D;&#x2009;1.82, 95&#x0025; CI (1.35, 2.45)], smoking [OR&#x2009;&#x003D;&#x2009;1.72, 95&#x0025; CI (1.35, 2.21)], hypertension [OR&#x2009;&#x003D;&#x2009;1.63, 95&#x0025; CI (1.08, 2.48)], patients with TNM stage II lung cancer [OR&#x2009;&#x003D;&#x2009;2.21, 95&#x0025; CI (1.22, 4.01)], transfusion [OR&#x2009;&#x003D;&#x2009;3.74, 95&#x0025; CI (2.28, 6.12)] were associated with an increased risk of postoperative AF after lung cancer surgery.</p>
</sec><sec><title>Conclusions</title>
<p>This study suggesting that factors such as age &#x003E;65 years, male gender, smoking, hypertension, elevated postoperative BNP levels, TNM stage II, and perioperative blood transfusion may be associated with an increased risk of postoperative AF in lung cancer patients.</p>
</sec><sec><title>Systematic Review Registration</title>
<p><ext-link ext-link-type="uri" xlink:href="https://www.crd.york.ac.uk/PROSPERO/view/CRD420251176315">https://www.crd.york.ac.uk/PROSPERO/view/CRD420251176315</ext-link>, Prospero CRD420251176315.</p>
</sec>
</abstract>
<kwd-group>
<kwd>atrial fibrillation</kwd>
<kwd>lung cancer</kwd>
<kwd>meta-analysis</kwd>
<kwd>risk factors</kwd>
<kwd>surgery</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement></funding-group><counts>
<fig-count count="8"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="45"/><page-count count="13"/><word-count count="6548"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Cardio-Oncology</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="background"><title>Background</title>
<p>Lung cancer ranks among the leading causes of cancer-related deaths worldwide. According to global cancer burden data, its incidence and mortality rates remain high in both men and women, with an upward trend driven by factors such as smoking and environmental pollution (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Treatment options for lung cancer primarily include surgery, radiotherapy, chemotherapy, and targeted therapy (<xref ref-type="bibr" rid="B3">3</xref>). Surgical resection is considered one of the most effective curative approaches for early-stage lung cancer (<xref ref-type="bibr" rid="B4">4</xref>). However, while lung cancer surgery significantly improves patient survival rates, postoperative complications remain a critical factor affecting patient prognosis and quality of life (<xref ref-type="bibr" rid="B5">5</xref>).</p>
<p>Atrial fibrillation (AF), a common arrhythmia, exhibits a marked increase in incidence with advancing age. AF not only increases the risk of stroke and heart failure but is also closely associated with elevated mortality rates (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Among lung cancer patients, AF is one of the common postoperative complications. Studies indicate that the incidence of AF after lung cancer surgery is higher than in the general population and is closely related to postoperative recovery, length of hospital stay, and mortality rates (<xref ref-type="bibr" rid="B8">8</xref>). With continuous advancements in surgical techniques and treatment methods, the prevention and management of postoperative complications have become a research focus (<xref ref-type="bibr" rid="B9">9</xref>). Identifying risk factors for postoperative AF in lung cancer patients is crucial for reducing its incidence and improving patient quality of life.</p>
<p>The pathogenesis of AF is complex, involving multiple factors including cardiac structural and electrophysiological changes, postoperative stress responses, inflammatory reactions, and oxidative stress (<xref ref-type="bibr" rid="B10">10</xref>). Lung cancer surgery itself poses significant physiological challenges to patients (<xref ref-type="bibr" rid="B11">11</xref>). Factors such as surgical trauma, anesthesia, and hemodynamic changes during the procedure may trigger or exacerbate AF (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Particularly in patients with advanced lung cancer, severe systemic inflammatory responses and cardiovascular burden following surgery may further elevate the risk of AF.</p>
<p>Although existing studies (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>) have explored the mechanisms and risk factors for postoperative AF in lung cancer patients, conclusions remain inconsistent due to limitations in sample size, study design, and regional variations. Therefore, this meta-analysis aims to comprehensively identify these risk factors, thereby informing improved postoperative management and care strategies for lung cancer patients. This approach seeks to enhance patient quality of life, reduce postoperative complications, and advance research in the prevention and treatment of cardiovascular complications following lung cancer surgery.</p>
</sec>
<sec id="s2" sec-type="methods"><title>Methods</title>
<p>This systematic evaluation and meta-analysis will strictly follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (<xref ref-type="bibr" rid="B16">16</xref>). And it is registered in Prospero with registration number CRD420251176315.</p>
</sec>
<sec id="s3"><title>Literature retrieval</title>
<p>This study searched PubMed, Embase, Cochrane Library, and Web of Science databases. The search cutoff date was October 20, 2025. Search terms (Mesh and free text) included: (Lung Neoplasms [Mesh] OR Lung Neoplasms [Title/Abstract]) and (Atrial Fibrillation [Mesh] OR Atrial Fibrillation [Title/Abstract]) and (Risk Factors [Mesh] OR Factor, Risk [Title/Abstract]). We will also manually search the reference lists of included studies to ensure comprehensive inclusion of relevant research.</p>
</sec>
<sec id="s4"><title>Inclusion and exclusion criteria</title>
<sec id="s4a"><title>Inclusion criteria</title>
<list list-type="order">
<list-item>
<p>Study Type: Prospective or retrospective observational studies (cohort studies and case control).</p></list-item>
<list-item>
<p>Study Population: Adult patients (age&#x2009;&#x003E;&#x2009;18) with lung cancer undergoing surgery.</p></list-item>
<list-item>
<p>Exposure: The exposure factor is the occurrence of postoperative AF, meaning the patient develops AF following lung cancer surgery, regardless of whether the occurrence is a single episode or recurrent.</p></list-item>
<list-item>
<p>Study Results: Provided or calculable effect sizes for risk factors (OR values, RR values, and their 95&#x0025; confidence intervals).</p></list-item>
<list-item>
<p>Assessable literature quality with complete data.</p></list-item>
</list>
</sec>
<sec id="s4b"><title>Exclusion criteria</title>
<list list-type="order">
<list-item>
<p>Studies with duplicate publications or overlapping data.</p></list-item>
<list-item>
<p>Case reports, conference abstracts, reviews, commentaries, or animal studies.</p></list-item>
<list-item>
<p>Studies that do not clearly distinguish between AF and other arrhythmias or have methodological issues impacting data reliability.</p></list-item>
<list-item>
<p>Studies where full-text access is unavailable.</p></list-item>
</list>
</sec>
</sec>
<sec id="s5"><title>Study selection</title>
<p>During the literature screening process, two researchers independently used EndNote 21 software to initially screen the literature obtained from the search, first through the titles and abstracts, and then to exclude literature that clearly did not meet the inclusion criteria. Subsequently, the remaining literature was reviewed by reading the full text in its entirety to further determine whether it met the inclusion and exclusion criteria. In case of disagreement between the two researchers during the screening process, it would be resolved through discussion and negotiation; if the negotiation still failed to reach a consensus, a third researcher would be invited to adjudicate to ensure the objectivity and consistency of the screening process.</p>
</sec>
<sec id="s6"><title>Data extractions</title>
<p>This study was conducted by two researchers who independently extracted relevant data from the eligible literature using an Excel sheet based on the inclusion criteria. The extraction included the basic information of the study (first author, year of publication, country and study design), the basic characteristics of the study population (sample size, number of AF, gender, mean age (years) and the regression analysis. In the process of data extraction, if two investigators disagreed on the data, it would be resolved through negotiation, and if no agreement could be reached, a third investigator would adjudicate to ensure the accuracy and consistency of data extraction.</p>
</sec>
<sec id="s7"><title>Quality evaluation</title>
<p>The types of studies included in this study will be assessed using different quality assessment tools: for case-control and cohort studies, the NOS (Newcastle-Ottawa Scale) (<xref ref-type="bibr" rid="B17">17</xref>) quality assessment tool will be used, which evaluates the intrinsic bias of the studies through three main domains (study selectivity, comparability, and assessment of outcomes), focusing on sample selection, the relationship between exposure and relationship between exposure and outcome, and control of confounders; these quality assessment tools ensure that the included studies have a high-quality evidence base.</p>
</sec>
<sec id="s8"><title>Statistical analysis</title>
<p>In this study, the random effects model was adopted due to the high degree of heterogeneity among the included studies. The risk ratio (OR) and corresponding 95&#x0025; confidence interval (CI) were extracted for each study and then pooled together. To account for the variability between studies, the random effects model was chosen, which provides a more generalized estimate of the overall effect size when there is significant heterogeneity. The heterogeneity of the combined studies was assessed using the I&#x00B2; statistic. If the I&#x00B2; value was greater than 50&#x0025;, it was indicative of substantial heterogeneity, and further exploration of potential sources of this heterogeneity was required. In cases of high heterogeneity, sensitivity analyses may be performed to identify any factors that could influence the overall effect sizes. To detect publication bias, a funnel plot was generated, and its asymmetry was examined. If the funnel plot showed signs of asymmetry, Egger&#x0027;s test was performed to assess the statistical significance of the bias. A <italic>p</italic>-value of &#x003C;0.05 suggests the presence of publication bias, while a <italic>p</italic>-value of&#x2009;&#x003E;&#x2009;0.05 indicates no significant bias. If necessary, the trim-and-fill method may be applied to adjust for any potential publication bias and verify the robustness of the results. Finally, the combined effect sizes will be reported as odds ratios (ORs) with their respective 95&#x0025; confidence intervals (CIs) to facilitate the interpretation of the findings and allow for statistical inference.</p>
</sec>
<sec id="s9" sec-type="results"><title>Results</title>
<sec id="s9a"><title>Literature search results</title>
<p>As shown in <xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>, a total of 1,210 articles were retrieved from PubMed (<italic>n</italic>&#x2009;&#x003D;&#x2009;102), Embase (<italic>n</italic>&#x2009;&#x003D;&#x2009;561), Cochrane Library (<italic>n</italic>&#x2009;&#x003D;&#x2009;48), and Web of Science (<italic>n</italic>&#x2009;&#x003D;&#x2009;499). After removing 394 duplicate records, 799 articles were excluded based on title and abstract screening, and 3 articles were excluded after full-text review. Ultimately, 13 articles (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>) were included.</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Literature search flow chart.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g001.tif"><alt-text content-type="machine-generated">Flowchart detailing systematic review process: Identification phase screened 1,210 records from databases, removing 788 for duplicates and ineligibility. Screening phase involved 814 records, excluding 799 after title/abstract review. Fifteen reports sought and assessed for eligibility, with three excluded. Final inclusion phase retained thirteen studies.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s9b"><title>Table of basic characteristics</title>
<p>This study included 13 research articles: 1 case-control study and 12 cohort studies, involving a total of 20,701 lung cancer patients. Among them, 2,436 developed AFs, with ages ranging from 62.3 to 70.2 years. Detailed baseline characteristics are presented in <xref ref-type="table" rid="T1">Table&#x00A0;1</xref>.</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Table of basic characteristics.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Study</th>
<th valign="top" align="center">Year</th>
<th valign="top" align="center">Country</th>
<th valign="top" align="center">Study design</th>
<th valign="top" align="center">Sample size</th>
<th valign="top" align="center">No of AF</th>
<th valign="top" align="center">Gender (M/F)</th>
<th valign="top" align="center">Mean age (years)</th>
<th valign="top" align="center">Regression model</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Cardinale</td>
<td valign="top" align="left">2007</td>
<td valign="top" align="left">Italy</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">400</td>
<td valign="top" align="center">72</td>
<td valign="top" align="center">271/129</td>
<td valign="top" align="center">64</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Chen</td>
<td valign="top" align="left">2025</td>
<td valign="top" align="left">China</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">208</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">124/84</td>
<td valign="top" align="center">69</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Ciszewski</td>
<td valign="top" align="left">2013</td>
<td valign="top" align="left">Poland</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">117</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">92/25</td>
<td valign="top" align="center">68</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Figas</td>
<td valign="top" align="left">2007</td>
<td valign="top" align="left">Poland</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">60/20</td>
<td valign="top" align="center">61.6</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Gong</td>
<td valign="top" align="left">2021</td>
<td valign="top" align="left">China</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">344</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">222/122</td>
<td valign="top" align="center">65</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Gong</td>
<td valign="top" align="left">2025</td>
<td valign="top" align="left">China</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">369</td>
<td valign="top" align="center">70</td>
<td valign="top" align="center">269/100</td>
<td valign="top" align="center">62.3</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Han</td>
<td valign="top" align="left">2024</td>
<td valign="top" align="left">China</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">2,920</td>
<td valign="top" align="center">153</td>
<td valign="top" align="center">1,345/1,675</td>
<td valign="top" align="center">70.1</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Imperatori</td>
<td valign="top" align="left">2012</td>
<td valign="top" align="left">Italy</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">454</td>
<td valign="top" align="center">45</td>
<td valign="top" align="center">369/85</td>
<td valign="top" align="center">65.4</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Ishibashi</td>
<td valign="top" align="left">2020</td>
<td valign="top" align="left">Japan</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">947</td>
<td valign="top" align="center">49</td>
<td valign="top" align="center">547/400</td>
<td valign="top" align="center">70.2</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Ivanovic</td>
<td valign="top" align="left">2014</td>
<td valign="top" align="left">Canada</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">363</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">168/195</td>
<td valign="top" align="center">70</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Iwata</td>
<td valign="top" align="left">2016</td>
<td valign="top" align="left">Japan</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">377</td>
<td valign="top" align="center">38</td>
<td valign="top" align="center">300/77</td>
<td valign="top" align="center">68.3</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Onaitis</td>
<td valign="top" align="left">2010</td>
<td valign="top" align="left">USA</td>
<td valign="top" align="left">cohort study</td>
<td valign="top" align="center">13,906</td>
<td valign="top" align="center">1,755</td>
<td valign="top" align="center">7,906/6,000</td>
<td valign="top" align="center">67</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
<tr>
<td valign="top" align="left">Zhang</td>
<td valign="top" align="left">2024</td>
<td valign="top" align="left">China</td>
<td valign="top" align="left">case-control</td>
<td valign="top" align="center">216</td>
<td valign="top" align="center">72</td>
<td valign="top" align="center">144/72</td>
<td valign="top" align="center">62.3</td>
<td valign="top" align="left">Multivariable logistic regression</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s9c"><title>Risk of bias results</title>
<p>As shown in <xref ref-type="table" rid="T2">Table&#x00A0;2</xref>, seven studies scored 9 points, four studies scored 8 points, and two studies scored 7 points. All articles included in this study were of high quality.</p>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>NOS scores results.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" colspan="10">Cohort study</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" align="left">Study</th>
<th valign="top" align="center">Representativeness of the exposed group</th>
<th valign="top" align="center">Selection of non-exposed groups</th>
<th valign="top" align="center">Determination of exposure factors</th>
<th valign="top" align="center">Identification of outcome indicators not yet to be observed at study entry</th>
<th valign="top" align="center">Comparability of exposed and unexposed groups considered in design and statistical analysis</th>
<th valign="top" align="center">design and statistical analysis</th>
<th valign="top" align="center">Adequacy of the study&#x0027;s evaluation of the outcome</th>
<th valign="top" align="center">Adequacy of follow-up in exposed and unexposed groups</th>
<th valign="top" align="center">Total scores</th>
</tr>
<tr>
<td valign="top" align="left">Cardinale 2007</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Chen 2025</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">Ciszewski 2013</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">Figas 2007</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Gong 2021</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Gong 2025</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Han 2024</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<td valign="top" align="left">Imperatori 2012</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Ishibashi 2020</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">Ivanovic 2014</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">Iwata 2016</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
<tr>
<td valign="top" align="left">Onaitis 2010</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">/</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<th valign="top" align="left" colspan="10">Case control</th>
</tr>
<tr>
<th valign="top" align="left">Study</th>
<th valign="top" align="center">Is the case definition adequate?</th>
<th valign="top" align="center">Representativeness of the cases</th>
<th valign="top" align="center">Determination of control group</th>
<th valign="top" align="center">Definition of Controls</th>
<th valign="top" align="center">Comparability of cases and controls based on the design or analysis</th>
<th valign="top" align="center">Ascertainment of exposure</th>
<th valign="top" align="center">Same method of ascertainment for cases and controls</th>
<th valign="top" align="center">Non response</th>
<th valign="top" align="center">Total scores</th>
</tr>
<tr>
<td valign="top" align="left">Zhang 2024</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">&#x002A;</td>
<td valign="top" align="center">9</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s10"><title>Meta-analysis results</title>
<sec id="s10a"><title>Age&#x2009;&#x003E;&#x2009;65</title>
<p>8 studies reported age &#x003E;65 years. Heterogeneity was high (I&#x00B2;&#x2009;&#x003D;&#x2009;89.6&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>) indicated that age &#x003E;65 was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;1.68, 95&#x0025; CI (1.30, 2.16)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S1</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Forest plot of the meta-analysis of age &#x003E;65 years.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g002.tif"><alt-text content-type="machine-generated">Forest plot showing the odds ratios (OR) with confidence intervals (CI) for various studies. Each study is represented by a square proportional to its weight, with horizontal lines indicating the CI. The central vertical dashed line represents the null effect (OR=1). Individual study results vary, with overall OR of 1.68 and CI of 1.30 to 2.16, signifying statistical significance, as indicated by the diamond shape. The note mentions random effects analysis with an I-squared of 89.6% and p-value of 0.000.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10b"><title>Postoperative high BNP</title>
<p>4 studies reported Postoperative high BNP. Heterogeneity was high (I&#x00B2;&#x2009;&#x003D;&#x2009;85.9&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>) indicated that Postoperative high BNP was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;3.82, 95&#x0025; CI (1.43, 10.25)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S2</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>Forest plot of the meta-analysis of postoperative high BNP.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g003.tif"><alt-text content-type="machine-generated">Forest plot displaying odds ratios (OR) and ninety-five percent confidence intervals (CI) for four studies. Cardinale (2007) OR: 20.10 (5.80&#x2013;69.40), Gong (2025) OR: 1.50 (1.30&#x2013;1.90), Iwata (2016) OR: 2.67 (1.21&#x2013;5.84), Zhang (2024) OR: 4.46 (1.52&#x2013;13.06). Overall OR: 3.82 (1.43&#x2013;10.25). Weights are derived from random effects analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10c"><title>Male</title>
<p>8 studies reported male. Heterogeneity was moderate (I&#x00B2;&#x2009;&#x003D;&#x2009;55.9&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.027), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>) indicated that male was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;1.82, 95&#x0025; CI (1.35, 2.45)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S3</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>Forest plot of the meta-analysis of male.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g004.tif"><alt-text content-type="machine-generated">Forest plot showing odds ratios (OR) with 95% confidence intervals (CI) for various studies. Studies listed include Figas (2007), Gong (2025), Han (2024), Imperatori (2012), Ishibashi (2020), Iwata (2016), Onaitis (2010), and Zhang (2024). OR values range from 1.46 to 14.29, with weights from random effects analysis varying from 1.05% to 29.95%. The overall effect size is 1.82 (95% CI 1.35 to 2.45), and heterogeneity is indicated by I-squared of 55.7% and p-value = 0.027.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10d"><title>Smoking</title>
<p>5 studies reported smoking. Heterogeneity was moderate (I&#x00B2;&#x2009;&#x003D;&#x2009;57.5&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.052), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>) indicated that smoking was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;1.72, 95&#x0025; CI (1.35, 2.21)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S4</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F5" position="float"><label>Figure&#x00A0;5</label>
<caption><p>Forest plot of the meta-analysis of smoking.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g005.tif"><alt-text content-type="machine-generated">Forest plot showing odds ratios (OR) with 95% confidence intervals for five studies: Chen, Ciszewski, Figas, Gong, and Zhang. Overall OR is 1.72 (1.35, 2.21). Weights, from random effects analysis, vary among studies. Horizontal lines represent confidence intervals, with vertical line at OR of 1. The plot aids in visualizing study impact and effect size.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10e"><title>Hypertension</title>
<p>6 studies reported hypertension. Heterogeneity was high (I&#x00B2;&#x2009;&#x003D;&#x2009;89.0&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>) indicated that hypertension was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;1.63, 95&#x0025; CI (1.08, 2.48)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S5</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F6" position="float"><label>Figure&#x00A0;6</label>
<caption><p>Forest plot of the meta-analysis of hypertension.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g006.tif"><alt-text content-type="machine-generated">Forest plot showing odds ratios (OR) with 95% confidence intervals (CI) for six studies. The studies are Chen (2025), Ciszewski (2013), Gong (2025), Han (2024), Imperatori (2012), and Onaitis (2010). Each study's OR with CI and weight percentage are listed. Overall OR is 1.63 (1.08, 2.48), with heterogeneity I-squared at 89.0% and p-value 0.000. Weights are from random-effects analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10f"><title>Patients with TNM stage II lung cancer</title>
<p>5 studies reported patients with TNM stage II lung cancer. Heterogeneity was high (I&#x00B2;&#x2009;&#x003D;&#x2009;94.2&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref>) indicated that patients with TNM stage II lung cancer was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;2.21, 95&#x0025; CI (1.22, 4.01)]. Sensitivity analysis (<xref ref-type="sec" rid="s19">Supplementary Figure S6</xref>) showed that the results were stable and not influenced by any single study.</p>
<fig id="F7" position="float"><label>Figure&#x00A0;7</label>
<caption><p>Forest plot of the meta-analysis of patients with TNM stage II lung cancer.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g007.tif"><alt-text content-type="machine-generated">Forest plot showing the odds ratios (OR) and 95% confidence intervals (CI) for five studies. Studies include Chen (2025), Gong (2021), Ishibashi (2020), Ivanovic (2014), and Onaitis (2010). The OR ranges from 1.24 to 3.18. The overall OR is 2.21 with a confidence interval of 1.22 to 4.01. Weights are from random effects analysis, with I-squared value at 94.2%.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10g"><title>Transfusion</title>
<p>3 studies reported transfusion. Heterogeneity was low (I&#x00B2;&#x2009;&#x003D;&#x2009;0&#x0025;, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.525), so a random-effects model was applied. The pooled analysis (<xref ref-type="fig" rid="F8">Figure&#x00A0;8</xref>) indicated that transfusion was associated with an increased risk of postoperative AF after lung cancer surgery [OR&#x2009;&#x003D;&#x2009;3.74, 95&#x0025; CI (2.28, 6.12)].</p>
<fig id="F8" position="float"><label>Figure&#x00A0;8</label>
<caption><p>Forest plot of the meta-analysis of transfusion.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-13-1768794-g008.tif"><alt-text content-type="machine-generated">Forest plot showing the results of a meta-analysis of three studies: Gong (2021), Imperatori (2012), and Ishibashi (2020). Each study's odds ratio (OR) with 95% confidence interval is represented by a black diamond, with corresponding values of 2.80, 3.61, and 5.91. The overall effect size is 3.74 with weights indicated as 34.42%, 40.75%, and 24.83%, totaling 100%. The plot includes a note about random effects analysis and shows a non-significant I-squared statistic of 0.0% with a p-value of 0.525.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s10h"><title>Publication bias</title>
<p>This study employed the Egger test and funnel plots to assess publication bias. Results (<xref ref-type="sec" rid="s19">Supplementary Figures S7&#x2013;S13</xref>) indicated that age &#x003E;65 (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.13), postoperative elevated BNP (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.59), male gender (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.18), smoking (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.94), hypertension (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.58), patients with TNM stage II lung cancer (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.48), and transfusion (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.09) indicated a low likelihood of publication bias. However, due to the limited number of studies on BNP and blood transfusion, readers should exercise caution when interpreting these findings.</p>
</sec>
<sec id="s10i"><title>Meta-regression</title>
<p>This study employed meta-regression to explore specific sources of heterogeneity in patients with Age &#x003E;65 years, Postoperative high BNP, hypertension, and TNM stage II lung cancer. Results (<xref ref-type="sec" rid="s19">Supplementary Table S1</xref>) indicate that Year, Country, and study design were not sources of heterogeneity.</p>
</sec>
</sec>
<sec id="s11" sec-type="discussion"><title>Discussion</title>
<p>This study systematically integrated existing research evidence on risk factors associated with postoperative AF in lung cancer patients. Data from multiple studies were combined using a random-effects model, and sensitivity analyses confirmed the stability of the results. Overall, age &#x003E;65 years, elevated postoperative BNP levels, male gender, smoking, hypertension, TNM stage II, and intraoperative blood transfusion were all significantly associated with an increased risk of postoperative AF in lung cancer patients.</p>
<p>First, age &#x003E;65 years has been demonstrated to be a significant risk factor for postoperative AF in lung cancer patients. Our findings indicate that elderly patients face a significantly higher risk of postoperative AF compared to younger patients (OR&#x2009;&#x003D;&#x2009;<sans-serif>1</sans-serif>.68). This observation aligns with results from cardiac surgery and thoracic surgery literature. Aging is closely associated with atrial structural remodeling, increased fibrosis, shortened effective refractory period, and autonomic dysregulation, making patients more susceptible to AF under surgical stress (<xref ref-type="bibr" rid="B31">31</xref>). Furthermore, elderly patients often present with comorbidities such as hypertension, coronary artery disease, and pulmonary disorders, which further exacerbate atrial pressure and inflammatory responses, providing a pathological basis for arrhythmia triggering (<xref ref-type="bibr" rid="B32">32</xref>). Therefore, elderly lung cancer patients should be prioritized for perioperative monitoring and management. Comprehensive preoperative cardiac function assessment and optimized management of comorbidities may help reduce the incidence of AF.</p>
<p>Second, this study identified elevated postoperative BNP levels as one of the most significant risk factors for AF (OR&#x2009;&#x003D;&#x2009;<sans-serif>3</sans-serif>.82). As a sensitive indicator of increased ventricular pressure or volume load, elevated BNP suggests myocardial stretching and heightened cardiac stress. Following lung resection, reduced pulmonary tissue volume alters pulmonary circulation dynamics (<xref ref-type="bibr" rid="B33">33</xref>). Concurrent postoperative inflammatory responses may place the heart under elevated stress, triggering neurohumoral dysregulation and atrial electrophysiological alterations that predispose to AF (<xref ref-type="bibr" rid="B34">34</xref>). Previous studies have demonstrated that elevated postoperative BNP predicts multiple adverse cardiac outcomes, including AF, heart failure, and mortality. These findings further reinforce the clinical value of BNP as an early risk assessment indicator (<xref ref-type="bibr" rid="B35">35</xref>). Therefore, enhanced continuous ECG monitoring is recommended for patients with elevated postoperative BNP, with prophylactic drug therapy (beta-blockers or amiodarone) administered when necessary (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>Regarding gender, this study revealed a higher risk of postoperative AF in male lung cancer patients compared to females (OR&#x2009;&#x003D;&#x2009;<sans-serif>1</sans-serif>.82). Evidence indicates that men are generally more prone to AF in the general population, potentially related to differences in sex hormone levels, atrial structure, and autonomic nervous system regulation. Higher smoking rates and more prevalent cardiovascular risk factors among men may also contribute to this mechanism (<xref ref-type="bibr" rid="B37">37</xref>). Although the specific biological mechanisms require further clarification, clinicians should recognize the higher susceptibility of male patients and enhance postoperative AF monitoring and risk assessment.</p>
<p>Smoking, another significant risk factor (OR&#x2009;&#x003D;&#x2009;<sans-serif>1</sans-serif>.72), exhibits a well-established biological basis for its association with AF. Smoking can induce arrhythmias through multiple pathways, including increased oxidative stress, exacerbated inflammatory responses, atrial structural remodeling, and autonomic imbalance. Additionally, long-term smokers often develop chronic obstructive pulmonary disease (COPD), whose lung function impairment and increased right ventricular workload further elevate the risk of AF (<xref ref-type="bibr" rid="B38">38</xref>). Given the high prevalence of smoking among lung cancer patients, this factor significantly influences postoperative arrhythmias (<xref ref-type="bibr" rid="B39">39</xref>). Preoperative smoking cessation and postoperative pulmonary function management should be prioritized clinical interventions.</p>
<p>Hypertension was also confirmed to be significantly associated with AF (OR&#x2009;&#x003D;&#x2009;<sans-serif>1</sans-serif>.63). Hypertension-induced left ventricular hypertrophy, atrial enlargement, and atrial fibrosis form a critical foundation for AF development. Surgical stress and perioperative hemodynamic fluctuations further increase cardiac burden in hypertensive patients, predisposing them to arrhythmias (<xref ref-type="bibr" rid="B40">40</xref>). Consistent with prior cardiothoracic surgery literature, this study underscores the importance of perioperative blood pressure management (<xref ref-type="bibr" rid="B41">41</xref>). Optimizing blood pressure control and avoiding significant intraoperative fluctuations or rapid changes may help reduce the risk of AF.</p>
<p>This study found that patients with TNM stage II had a significantly higher risk of AF (OR&#x2009;&#x003D;&#x2009;<sans-serif>2</sans-serif>.21) compared to other stages. This result may reflect the impact of tumor progression on patients&#x0027; overall physical condition, inflammatory levels, and nutritional status. Patients with higher tumor burden often undergo more complex procedures, experience greater surgical trauma, and exhibit stronger inflammatory responses during surgery, thereby increasing the risk of arrhythmias (<xref ref-type="bibr" rid="B42">42</xref>). Additionally, tumor-induced metabolic alterations and immune dysregulation may contribute to AF development. Although existing literature on this association is limited, this study provides new evidence suggesting enhanced postoperative cardiac monitoring for patients with advanced lung cancer.</p>
<p>Among perioperative factors, blood transfusion was found to significantly increase the risk of AF (OR&#x2009;&#x003D;&#x2009;<sans-serif>3</sans-serif>.74). Transfusion may elevate cardiac stress through mechanisms such as triggering inflammatory responses, altering blood viscosity, and inducing volume overload. Furthermore, transfusion is often associated with complex conditions including surgical trauma, significant blood loss, and prolonged operative time&#x2014;all factors potentially triggering postoperative AF (<xref ref-type="bibr" rid="B43">43</xref>). Reducing transfusion rates, adopting restrictive transfusion strategies, and optimizing intraoperative hemostasis techniques may all contribute to decreasing AF events.</p>
<p>In this study, we highlight the potential role of cardiac ultrasound imaging techniques, particularly speckle tracking echocardiography, in atrial fibrillation risk stratification. Speckle tracking echocardiography sensitively detects subclinical left atrial dysfunction and pathological remodeling even in the absence of overt left atrial enlargement, providing early risk indicators for atrial fibrillation development. These left atrial strain parameters, especially reservoir strain, have emerged as sensitive markers for assessing atrial myocardial dysfunction, aiding in the identification of patients at high preoperative risk for AF (<xref ref-type="bibr" rid="B44">44</xref>). Particularly in lung cancer surgery, combining traditional clinical and biochemical risk factors with these advanced imaging techniques for preoperative assessment significantly enhances the predictive capability for postoperative AF occurrence. Looking ahead, the ongoing advancement of cardiac imaging technologies&#x2014;particularly the application of speckle tracking echocardiography&#x2014;will provide crucial complementary tools for personalized preoperative risk assessment and management (<xref ref-type="bibr" rid="B45">45</xref>). This will facilitate the early detection of potential arrhythmia risks and guide the development of tailored treatment strategies.</p>
</sec>
<sec id="s12"><title>Strengths and limitations</title>
<p>This study possesses multiple strengths. First, it was conducted in strict accordance with the methodological standards for systematic reviews and meta-analyses. The search scope covered multiple Chinese and English databases, minimizing literature omission and enhancing the comprehensiveness and reliability of the research. Second, by extracting multiple potential risk factors associated with postoperative AF in lung cancer patients, this study systematically evaluated multidimensional factors including preoperative characteristics, intraoperative procedures, and postoperative physiological changes, thereby enhancing the clinical interpretability of the results. Third, the random-effects model was uniformly applied for meta-analysis, adequately accounting for the impact of study heterogeneity on overall effects and ensuring robust results. Furthermore, sensitivity analyses were conducted to test the robustness of all significant factors, revealing no substantial influence from individual studies and further supporting the reliability of our conclusions.</p>
<p>However, several limitations should be noted in this study. First, most of the included studies were observational, which makes it challenging to eliminate selection bias, information bias, and other potential confounders. These factors may have impacted the strength of our causal inferences. Second, there were discrepancies in the definitions of risk factors, diagnostic criteria, and AF monitoring methods across studies, which could have introduced heterogeneity. Moreover, for certain risk factors, such as blood transfusion and postoperative BNP levels, only a limited number of studies (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>) were available. As such, the stability of these findings needs further confirmation through additional high-quality research. Finally, several studies lacked a standardized follow-up period or did not specify the time window during which AF occurred, which could have influenced the estimation of the true postoperative AF incidence rate. These factors, along with the high heterogeneity and the limited number of studies for certain variables, reduce the robustness of our results.</p>
</sec>
<sec id="s13" sec-type="conclusions"><title>Conclusion</title>
<p>This study suggesting that factors such as age &#x003E;65 years, male gender, smoking, hypertension, elevated postoperative BNP levels, TNM stage II, and perioperative blood transfusion may be associated with an increased risk of postoperative AF in lung cancer patients. These factors involve patient baseline conditions, tumor characteristics, and perioperative physiological stress, potentially playing a role in the pathogenesis of AF. Although this study provides valuable reference information, its conclusions require further validation in more high-quality prospective studies due to limitations in the design types and heterogeneity of the included studies. Overall, identifying potential high-risk factors can assist clinicians in enhancing perioperative monitoring and risk management, thereby providing a basis for improving postoperative arrhythmia-related outcomes in lung cancer patients.</p>
</sec>
</body>
<back>
<sec id="s14" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s19">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s15" sec-type="author-contributions"><title>Author contributions</title>
<p>JZ: Visualization, Data curation, Methodology, Validation, Supervision, Project administration, Conceptualization, Investigation, Software, Writing &#x2013; review &#x0026; editing, Resources, Funding acquisition, Writing &#x2013; original draft, Formal analysis. SL: Project administration, Formal analysis, Methodology, Validation, Data curation, Visualization, Writing &#x2013; review &#x0026; editing, Software, Writing &#x2013; original draft, Conceptualization, Supervision, Funding acquisition, Resources, Investigation. JL: Methodology, Visualization, Formal analysis, Supervision, Writing &#x2013; original draft, Data curation, Software, Validation, Funding acquisition, Conceptualization, Resources, Writing &#x2013; review &#x0026; editing, Investigation, Project administration. YW: Software, Investigation, Writing &#x2013; review &#x0026; editing, Conceptualization, Supervision, Funding acquisition, Writing &#x2013; original draft, Visualization, Resources, Validation, Data curation, Project administration, Methodology, Formal analysis. MN: Writing &#x2013; review &#x0026; editing, Software, Investigation, Resources, Visualization, Funding acquisition, Methodology, Data curation, Validation, Writing &#x2013; original draft, Supervision, Formal analysis, Conceptualization, Project administration. CJ: Formal analysis, Visualization, Software, Data curation, Writing &#x2013; original draft, Funding acquisition, Conceptualization, Resources, Project administration, Methodology, Validation, Supervision, Writing &#x2013; review &#x0026; editing, Investigation. SH: Supervision, Methodology, Writing &#x2013; review &#x0026; editing, Software, Conceptualization, Writing &#x2013; original draft, Investigation, Visualization, Project administration, Funding acquisition, Formal analysis, Validation, Data curation, Resources. ZG: Validation, Writing &#x2013; review &#x0026; editing, Conceptualization, Investigation, Supervision, Funding acquisition, Methodology, Software, Formal analysis, Visualization, Project administration, Data curation, Writing &#x2013; original draft, Resources.</p>
</sec>
<sec id="s17" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s18" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s20" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s19" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2026.1768794/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2026.1768794/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material xlink:href="Datasheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname> <given-names>HM</given-names></name> <name><surname>Park</surname> <given-names>SY</given-names></name> <name><surname>Choi</surname> <given-names>Y</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name> <name><surname>Lee</surname> <given-names>Y</given-names></name></person-group>. <article-title>Molecular subtype changes after acquiring resistance to tarlatamab in small cell lung cancer</article-title>. <source>Drug Resist Updat</source>. (<year>2025</year>) <volume>79</volume>:<fpage>101198</fpage>. <pub-id pub-id-type="doi">10.1016/j.drup.2024.101198</pub-id><pub-id pub-id-type="pmid">39742708</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>C</given-names></name></person-group>. <article-title>Neuron-tumor crosstalk fuels small cell lung cancer</article-title>. <source>Trends Pharmacol Sci</source>. (<year>2025</year>) <volume>46</volume>(<issue>11</issue>):<fpage>1041</fpage>&#x2013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2025.10.007</pub-id><pub-id pub-id-type="pmid">41235999</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>M</given-names></name> <name><surname>Deng</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name></person-group>. <article-title>Clinical advances and challenges in targeting FGF/FGFR signaling in lung cancer</article-title>. <source>Mol Cancer</source>. (<year>2024</year>) <volume>23</volume>(<issue>1</issue>):<fpage>256</fpage>. <pub-id pub-id-type="doi">10.1186/s12943-024-02167-9</pub-id><pub-id pub-id-type="pmid">39543657</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardavella</surname> <given-names>G</given-names></name> <name><surname>Frille</surname> <given-names>A</given-names></name> <name><surname>Chalela</surname> <given-names>R</given-names></name> <name><surname>Sreter</surname> <given-names>KB</given-names></name> <name><surname>Petersen</surname> <given-names>RH</given-names></name> <name><surname>Novoa</surname> <given-names>N</given-names></name><etal/></person-group> <article-title>How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?</article-title> <source>Eur Respir Rev</source>. (<year>2024</year>) <volume>33</volume>(<issue>172</issue>):<fpage>230232</fpage>. <pub-id pub-id-type="doi">10.1183/16000617.0232-2023</pub-id><pub-id pub-id-type="pmid">38925794</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>M</given-names></name> <name><surname>Zhang</surname> <given-names>Q</given-names></name></person-group>. <article-title>Intersection between lung cancer and neuroscience: opportunities and challenges</article-title>. <source>Cancer Lett</source>. (<year>2025</year>) <volume>621</volume>:<fpage>217701</fpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2025.217701</pub-id><pub-id pub-id-type="pmid">40194655</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joglar</surname> <given-names>JA</given-names></name> <name><surname>Chung</surname> <given-names>MK</given-names></name> <name><surname>Armbruster</surname> <given-names>AL</given-names></name> <name><surname>Benjamin</surname> <given-names>EJ</given-names></name> <name><surname>Chyou</surname> <given-names>JY</given-names></name> <name><surname>Cronin</surname> <given-names>EM</given-names></name><etal/></person-group> <article-title>2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines</article-title>. <source>Circulation</source>. (<year>2024</year>) <volume>149</volume>(<issue>1</issue>):<fpage>e1</fpage>&#x2013;<lpage>e156</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000001193</pub-id><pub-id pub-id-type="pmid">38033089</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siontis</surname> <given-names>KC</given-names></name> <name><surname>Noseworthy</surname> <given-names>PA</given-names></name> <name><surname>Friedman</surname> <given-names>PA</given-names></name></person-group>. <article-title>Detection of atrial fibrillation in patients after stroke</article-title>. <source>Lancet Neurol</source>. (<year>2024</year>) <volume>23</volume>(<issue>4</issue>):<fpage>335</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(24)00051-6</pub-id><pub-id pub-id-type="pmid">38508829</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>C</given-names></name> <name><surname>Niu</surname> <given-names>Z</given-names></name> <name><surname>Zhu</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>T</given-names></name> <name><surname>Xu</surname> <given-names>Y</given-names></name> <name><surname>Yan</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Development and external validation of a novel model for predicting new clinically important atrial fibrillation after thoracoscopic anatomical lung cancer surgery: a multicenter retrospective cohort study</article-title>. <source>Int J Surg</source>. (<year>2024</year>) <volume>110</volume>(<issue>3</issue>):<fpage>1645</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/JS9.0000000000001006</pub-id><pub-id pub-id-type="pmid">38181118</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngufor</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>N</given-names></name> <name><surname>Van Houten</surname> <given-names>HK</given-names></name> <name><surname>Holmes</surname><given-names>DR</given-names><suffix>Jr</suffix></name> <name><surname>Graff-Radford</surname> <given-names>J</given-names></name> <name><surname>Alkhouli</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Causal machine learning for left atrial appendage occlusion in patients with atrial fibrillation</article-title>. <source>JACC Clin Electrophysiol</source>. (<year>2025</year>) <volume>11</volume>(<issue>5</issue>):<fpage>977</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacep.2024.12.013</pub-id><pub-id pub-id-type="pmid">39945715</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname> <given-names>SK</given-names></name> <name><surname>Kim</surname> <given-names>KH</given-names></name> <name><surname>Noh</surname> <given-names>JM</given-names></name> <name><surname>Oh</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>G</given-names></name> <name><surname>Kim</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Development of learning-based predictive models for radiation-induced atrial fibrillation in non-small cell lung cancer patients by integrating patient-specific clinical, dosimetry, and diagnostic information</article-title>. <source>Radiother Oncol</source>. (<year>2024</year>) <volume>201</volume>:<fpage>110566</fpage>. <pub-id pub-id-type="doi">10.1016/j.radonc.2024.110566</pub-id><pub-id pub-id-type="pmid">39362606</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walls</surname> <given-names>GM</given-names></name> <name><surname>McCann</surname> <given-names>C</given-names></name> <name><surname>O&#x0027;Connor</surname> <given-names>J</given-names></name> <name><surname>O&#x2019;Sullivan</surname> <given-names>A</given-names></name> <name><surname>Johnston</surname> <given-names>DI</given-names></name> <name><surname>McAleese</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis</article-title>. <source>Radiother Oncol</source>. (<year>2024</year>) <volume>192</volume>:<fpage>110085</fpage>. <pub-id pub-id-type="doi">10.1016/j.radonc.2024.110085</pub-id><pub-id pub-id-type="pmid">38184145</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajabnoor</surname> <given-names>AM</given-names></name> <name><surname>Parisi</surname> <given-names>R</given-names></name> <name><surname>Zghebi</surname> <given-names>SS</given-names></name> <name><surname>Ashcroft</surname> <given-names>DM</given-names></name> <name><surname>Faivre-Finn</surname> <given-names>C</given-names></name> <name><surname>Morris</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009&#x2013;2019</article-title>. <source>Cancer</source>. (<year>2024</year>) <volume>130</volume>(<issue>8</issue>):<fpage>1316</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.35152</pub-id><pub-id pub-id-type="pmid">38115738</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohidinezhad</surname> <given-names>F</given-names></name> <name><surname>N&#x00FC;rnberg</surname> <given-names>L</given-names></name> <name><surname>Vaassen</surname> <given-names>F</given-names></name> <name><surname>Ma Ter Bekke</surname> <given-names>R</given-names></name> <name><surname>Jwl Aerts</surname> <given-names>H</given-names></name> <name><surname>El Hendriks</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy</article-title>. <source>Radiother Oncol</source>. (<year>2024</year>) <volume>201</volume>:<fpage>110544</fpage>. <pub-id pub-id-type="doi">10.1016/j.radonc.2024.110544</pub-id><pub-id pub-id-type="pmid">39341504</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>L</given-names></name> <name><surname>Mei</surname> <given-names>J</given-names></name></person-group>. <article-title>New predictive model of perioperative atrial fibrillation for thoracic surgery is needed</article-title>. <source>Ann Thorac Surg</source>. (<year>2024</year>) <volume>118</volume>(<issue>1</issue>):<fpage>287</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2023.12.004</pub-id><pub-id pub-id-type="pmid">38145702</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaaban</surname> <given-names>A</given-names></name> <name><surname>Scott</surname> <given-names>SS</given-names></name> <name><surname>Greenlee</surname> <given-names>AN</given-names></name> <name><surname>Binda</surname> <given-names>N</given-names></name> <name><surname>Noor</surname> <given-names>A</given-names></name> <name><surname>Webb</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms</article-title>. <source>J Mol Cell Cardiol</source>. (<year>2024</year>) <volume>194</volume>:<fpage>118</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2024.06.005</pub-id><pub-id pub-id-type="pmid">38897563</pub-id></mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname> <given-names>MJ</given-names></name> <name><surname>McKenzie</surname> <given-names>JE</given-names></name> <name><surname>Bossuyt</surname> <given-names>PM</given-names></name> <name><surname>Boutron</surname> <given-names>I</given-names></name> <name><surname>Hoffmann</surname> <given-names>TC</given-names></name> <name><surname>Mulrow</surname> <given-names>CD</given-names></name><etal/></person-group> <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>Br Med J</source>. (<year>2021</year>) <volume>372</volume>:<fpage>n71</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stang</surname> <given-names>A</given-names></name></person-group>. <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source>. (<year>2010</year>) <volume>25</volume>(<issue>9</issue>):<fpage>603</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-010-9491-z</pub-id><pub-id pub-id-type="pmid">20652370</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardinale</surname> <given-names>D</given-names></name> <name><surname>Colombo</surname> <given-names>A</given-names></name> <name><surname>Sandri</surname> <given-names>MT</given-names></name> <name><surname>Lamantia</surname> <given-names>G</given-names></name> <name><surname>Colombo</surname> <given-names>N</given-names></name> <name><surname>Civelli</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer</article-title>. <source>Circulation</source>. (<year>2007</year>) <volume>115</volume>(<issue>11</issue>):<fpage>1339</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.647008</pub-id><pub-id pub-id-type="pmid">17339553</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>XY</given-names></name> <name><surname>Wu</surname> <given-names>Y</given-names></name> <name><surname>Zheng</surname> <given-names>XF</given-names></name></person-group>. <article-title>Postoperative arrhythmias in geriatric lung cancer patients undergoing thoracoscopic surgery: an exploration of prevalence and influencing factors</article-title>. <source>Perioper Med</source>. (<year>2025</year>) <volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1186/s13741-025-00538-4</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciszewski</surname> <given-names>P</given-names></name> <name><surname>Tyczka</surname> <given-names>J</given-names></name> <name><surname>Nadolski</surname> <given-names>J</given-names></name> <name><surname>Roszak</surname> <given-names>M</given-names></name> <name><surname>Dyszkiewicz</surname> <given-names>W</given-names></name></person-group>. <article-title>Lower preoperative fluctuation of heart rate variability is an independent risk factor for postoperative atrial fibrillation in patients undergoing major pulmonary resection</article-title>. <source>Interact Cardiovasc Thorac Surg</source>. (<year>2013</year>) <volume>17</volume>(<issue>4</issue>):<fpage>680</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivt238</pub-id><pub-id pub-id-type="pmid">23832838</pub-id></mixed-citation></ref>
<ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figas-Powajbo</surname> <given-names>E</given-names></name> <name><surname>Gawor</surname> <given-names>Z</given-names></name> <name><surname>Kozak</surname> <given-names>J</given-names></name></person-group>. <article-title>Perioperative cardiac arrhythmias in patients undergoing surgical treatment for lung cancer</article-title>. <source>Pol Arch Med Wewn</source>. (<year>2007</year>) <volume>117</volume>(<issue>7</issue>):<fpage>290</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.20452/pamw.160</pub-id><pub-id pub-id-type="pmid">17966594</pub-id></mixed-citation></ref>
<ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Yao</surname> <given-names>S</given-names></name> <name><surname>Xiao</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Risk factors and survival analysis of arrhythmia following lung cancer surgery: a retrospective study</article-title>. <source>J Thorac Dis</source>. (<year>2021</year>) <volume>13</volume>(<issue>2</issue>):<fpage>847</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.21037/jtd-20-2740</pub-id><pub-id pub-id-type="pmid">33717558</pub-id></mixed-citation></ref>
<ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>ZW</given-names></name> <name><surname>Hella</surname> <given-names>S</given-names></name> <name><surname>Shi</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>XY</given-names></name></person-group>. <article-title>Construction of a risk prediction model for postoperative atrial fibrillation in lung cancer patients based on multi-dimensional feature fusion and ensemble learning</article-title>. <source>Front Cardiovasc Med</source>. (<year>2025</year>) <volume>12</volume>:<fpage>1679973</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2025.1679973</pub-id><pub-id pub-id-type="pmid">41210335</pub-id></mixed-citation></ref>
<ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>Y</given-names></name> <name><surname>Guo</surname> <given-names>C</given-names></name> <name><surname>Zhu</surname> <given-names>QM</given-names></name> <name><surname>Liu</surname> <given-names>ZJ</given-names></name> <name><surname>Zhang</surname> <given-names>YL</given-names></name> <name><surname>Li</surname> <given-names>SQ</given-names></name><etal/></person-group> <article-title>Risk factors and prognosis of perioperative atrial fibrillation in elderly patients undergoing VATS lung surgery: a retrospective cohort study</article-title>. <source>Vasc Health Risk Manag</source>. (<year>2024</year>) <volume>20</volume>:<fpage>289</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.2147/VHRM.S463648</pub-id><pub-id pub-id-type="pmid">38978993</pub-id></mixed-citation></ref>
<ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperatori</surname> <given-names>A</given-names></name> <name><surname>Mariscalco</surname> <given-names>G</given-names></name> <name><surname>Riganti</surname> <given-names>G</given-names></name> <name><surname>Rotolo</surname> <given-names>N</given-names></name> <name><surname>Conti</surname> <given-names>V</given-names></name> <name><surname>Dominioni</surname> <given-names>L</given-names></name></person-group>. <article-title>Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study</article-title>. <source>J Cardiothorac Surg</source>. (<year>2012</year>) <volume>7</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8090-7-4</pub-id><pub-id pub-id-type="pmid">22233837</pub-id></mixed-citation></ref>
<ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname> <given-names>H</given-names></name> <name><surname>Wakejima</surname> <given-names>R</given-names></name> <name><surname>Asakawa</surname> <given-names>A</given-names></name> <name><surname>Baba</surname> <given-names>S</given-names></name> <name><surname>Nakashima</surname> <given-names>Y</given-names></name> <name><surname>Seto</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Postoperative atrial fibrillation in lung cancer lobectomy-analysis of risk factors and prognosis</article-title>. <source>World J Surg</source>. (<year>2020</year>) <volume>44</volume>(<issue>11</issue>):<fpage>3952</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00268-020-05694-w</pub-id><pub-id pub-id-type="pmid">32681318</pub-id></mixed-citation></ref>
<ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanovic</surname> <given-names>J</given-names></name> <name><surname>Maziak</surname> <given-names>DE</given-names></name> <name><surname>Ramzan</surname> <given-names>S</given-names></name> <name><surname>McGuire</surname> <given-names>AL</given-names></name> <name><surname>Villeneuve</surname> <given-names>PJ</given-names></name> <name><surname>Gilbert</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection</article-title>. <source>Interact Cardiovasc Thorac Surg</source>. (<year>2014</year>) <volume>18</volume>(<issue>3</issue>):<fpage>340</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/icvts/ivt520</pub-id><pub-id pub-id-type="pmid">24336699</pub-id></mixed-citation></ref>
<ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname> <given-names>T</given-names></name> <name><surname>Nagato</surname> <given-names>K</given-names></name> <name><surname>Nakajima</surname> <given-names>T</given-names></name> <name><surname>Suzuki</surname> <given-names>H</given-names></name> <name><surname>Yoshida</surname> <given-names>S</given-names></name> <name><surname>Yoshino</surname> <given-names>I</given-names></name></person-group>. <article-title>Risk factors predictive of atrial fibrillation after lung cancer surgery</article-title>. <source>Surg Today</source>. (<year>2016</year>) <volume>46</volume>(<issue>8</issue>):<fpage>877</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/s00595-015-1258-4</pub-id><pub-id pub-id-type="pmid">26471506</pub-id></mixed-citation></ref>
<ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaitis</surname> <given-names>M</given-names></name> <name><surname>D&#x0027;Amico</surname> <given-names>T</given-names></name> <name><surname>Zhao</surname> <given-names>Y</given-names></name> <name><surname>O&#x0027;Brien</surname> <given-names>S</given-names></name> <name><surname>Harpole</surname> <given-names>D</given-names></name></person-group>. <article-title>Risk factors for atrial fibrillation after lung cancer surgery: analysis of the society of thoracic surgeons general thoracic surgery database</article-title>. <source>Ann Thorac Surg</source>. (<year>2010</year>) <volume>90</volume>(<issue>2</issue>):<fpage>368</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2010.03.100</pub-id><pub-id pub-id-type="pmid">20667313</pub-id></mixed-citation></ref>
<ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Wu</surname> <given-names>H</given-names></name> <name><surname>Luo</surname> <given-names>J</given-names></name></person-group>. <article-title>Risk factors associated with atrial fibrillation following lung cancer surgery: a multi-center case-control study</article-title>. <source>Asian J Surg</source>. (<year>2024</year>) <volume>47</volume>(<issue>1</issue>):<fpage>176</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.asjsur.2023.06.108</pub-id><pub-id pub-id-type="pmid">37419802</pub-id></mixed-citation></ref>
<ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsaban</surname> <given-names>G</given-names></name> <name><surname>Ostrovsky</surname> <given-names>D</given-names></name> <name><surname>Alnsasra</surname> <given-names>H</given-names></name> <name><surname>Burrack</surname> <given-names>N</given-names></name> <name><surname>Gordon</surname> <given-names>M</given-names></name> <name><surname>Babayev</surname> <given-names>AS</given-names></name><etal/></person-group> <article-title>Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study</article-title>. <source>Eur Heart J</source>. (<year>2024</year>) <volume>45</volume>(<issue>5</issue>):<fpage>379</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehad726</pub-id><pub-id pub-id-type="pmid">37939798</pub-id></mixed-citation></ref>
<ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>R</given-names></name> <name><surname>Kim</surname> <given-names>MS</given-names></name> <name><surname>Yin</surname> <given-names>W</given-names></name> <name><surname>Liao</surname> <given-names>S</given-names></name> <name><surname>Zhu</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>X</given-names></name><etal/></person-group> <article-title>Contributions of common, rare, and somatic genetic variants to incidence of atrial fibrillation</article-title>. <source>JAMA Cardiol</source>. (<year>2025</year>) <volume>10</volume>(<issue>12</issue>):<fpage>1240</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jamacardio.2025.3664</pub-id><pub-id pub-id-type="pmid">41060636</pub-id></mixed-citation></ref>
<ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojiri</surname> <given-names>T</given-names></name> <name><surname>Yamamoto</surname> <given-names>K</given-names></name> <name><surname>Maeda</surname> <given-names>H</given-names></name> <name><surname>Takeuchi</surname> <given-names>Y</given-names></name> <name><surname>Ose</surname> <given-names>N</given-names></name> <name><surname>Susaki</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>A double-blind placebo-controlled study of the effects of olprinone, a specific phosphodiesterase III inhibitor, for preventing postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer</article-title>. <source>Chest</source>. (<year>2015</year>) <volume>148</volume>(<issue>5</issue>):<fpage>1285</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1378/chest.15-0852</pub-id><pub-id pub-id-type="pmid">26204331</pub-id></mixed-citation></ref>
<ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brecher</surname> <given-names>O</given-names></name> <name><surname>Gulati</surname> <given-names>H</given-names></name> <name><surname>Roistacher</surname> <given-names>N</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Shi</surname> <given-names>W</given-names></name> <name><surname>Thaler</surname> <given-names>HT</given-names></name><etal/></person-group> <article-title>Preoperative echocardiographic indices of diastolic dysfunction and brain natriuretic peptide in predicting postoperative atrial fibrillation after noncardiac surgery</article-title>. <source>Anesth Analg</source>. (<year>2017</year>) <volume>124</volume>(<issue>4</issue>):<fpage>1099</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1213/ANE.0000000000001471</pub-id><pub-id pub-id-type="pmid">27918330</pub-id></mixed-citation></ref>
<ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojiri</surname> <given-names>T</given-names></name> <name><surname>Maeda</surname> <given-names>H</given-names></name> <name><surname>Takeuchi</surname> <given-names>Y</given-names></name> <name><surname>Funakoshi</surname> <given-names>Y</given-names></name> <name><surname>Kimura</surname> <given-names>T</given-names></name> <name><surname>Maekura</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Predictive value of B-type natriuretic peptide for postoperative atrial fibrillation following pulmonary resection for lung cancer</article-title>. <source>Eur J Cardiothorac Surg</source>. (<year>2010</year>) <volume>37</volume>(<issue>4</issue>):<fpage>787</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcts.2009.09.043</pub-id><pub-id pub-id-type="pmid">19896864</pub-id></mixed-citation></ref>
<ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheggi</surname> <given-names>V</given-names></name> <name><surname>Salvicchi</surname> <given-names>A</given-names></name> <name><surname>Menale</surname> <given-names>S</given-names></name> <name><surname>Giovacchini</surname> <given-names>J</given-names></name> <name><surname>Fumagalli</surname> <given-names>S</given-names></name> <name><surname>Santamaria</surname> <given-names>E</given-names></name><etal/></person-group> <article-title>Clinical and echocardiographic predictors of postoperative atrial fibrillation in lung surgery: the role of left atrial remodelling</article-title>. <source>Intern Emerg Med</source>. (<year>2025</year>) <volume>20</volume>(<issue>4</issue>):<fpage>1097</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1007/s11739-025-03930-6</pub-id><pub-id pub-id-type="pmid">40198495</pub-id></mixed-citation></ref>
<ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedovati</surname> <given-names>MC</given-names></name> <name><surname>Giustozzi</surname> <given-names>M</given-names></name> <name><surname>Verdecchia</surname> <given-names>P</given-names></name> <name><surname>Pierpaoli</surname> <given-names>L</given-names></name> <name><surname>Conti</surname> <given-names>S</given-names></name> <name><surname>Verso</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Patients with cancer and atrial fibrillation treated with doacs: a prospective cohort study</article-title>. <source>Int J Cardiol</source>. (<year>2018</year>) <volume>269</volume>:<fpage>152</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2018.07.138</pub-id><pub-id pub-id-type="pmid">30077526</pub-id></mixed-citation></ref>
<ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Yang</surname> <given-names>P</given-names></name> <name><surname>Liu</surname> <given-names>H</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Hu</surname> <given-names>P</given-names></name> <name><surname>Ye</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>Assessing causality between second-hand smoking and potentially associated diseases in multiple systems: a two-sample Mendelian randomization study</article-title>. <source>Nicotine Tob Res</source>. (<year>2024</year>) <volume>26</volume>(<issue>6</issue>):<fpage>678</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1093/ntr/ntad193</pub-id><pub-id pub-id-type="pmid">37788476</pub-id></mixed-citation></ref>
<ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassivi</surname> <given-names>SD</given-names></name> <name><surname>Allen</surname> <given-names>MS</given-names></name> <name><surname>Vanderwaerdt</surname> <given-names>GD</given-names></name> <name><surname>Ewoldt</surname> <given-names>LL</given-names></name> <name><surname>Cordes</surname> <given-names>ME</given-names></name> <name><surname>Wigle</surname> <given-names>DA</given-names></name><etal/></person-group> <article-title>Patient-centered quality indicators for pulmonary resection</article-title>. <source>Ann Thorac Surg</source>. (<year>2008</year>) <volume>86</volume>(<issue>3</issue>):<fpage>927</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.04.021</pub-id><pub-id pub-id-type="pmid">18721584</pub-id></mixed-citation></ref>
<ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georghiou</surname> <given-names>GP</given-names></name> <name><surname>Georghiou</surname> <given-names>P</given-names></name> <name><surname>Georgiou</surname> <given-names>A</given-names></name> <name><surname>Triposkiadis</surname> <given-names>F</given-names></name></person-group>. <article-title>Cardiac surgery and postoperative atrial fibrillation: the role of cancer</article-title>. <source>Medicina (Kaunas)</source>. (<year>2025</year>) <volume>61</volume>(<issue>10</issue>):<fpage>1815</fpage>. <pub-id pub-id-type="doi">10.3390/medicina61101815</pub-id><pub-id pub-id-type="pmid">41155802</pub-id></mixed-citation></ref>
<ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>D</given-names></name> <name><surname>Ye</surname> <given-names>H</given-names></name> <name><surname>Dong</surname> <given-names>M</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Dai</surname> <given-names>J</given-names></name> <name><surname>Le</surname> <given-names>H</given-names></name><etal/></person-group> <article-title>Development and internal validation of a nomogram to predict postoperative atrial fibrillation in elderly patients with lung cancer</article-title>. <source>J Thorac Dis</source>. (<year>2025</year>) <volume>17</volume>(<issue>9</issue>):<fpage>6711</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.21037/jtd-2025-533</pub-id><pub-id pub-id-type="pmid">41158410</pub-id></mixed-citation></ref>
<ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gridelli</surname> <given-names>C</given-names></name> <name><surname>Cigolari</surname> <given-names>S</given-names></name> <name><surname>Gallo</surname> <given-names>C</given-names></name> <name><surname>Manzione</surname> <given-names>L</given-names></name> <name><surname>Ianniello</surname> <given-names>GP</given-names></name> <name><surname>Frontini</surname> <given-names>L</given-names></name><etal/></person-group> <article-title>Activity and toxicity of gemcitabine and gemcitabine&#x002B;vinorelbine in advanced non-small-cell lung cancer elderly patients: phase II data from the multicenter Italian lung cancer in the elderly study (MILES) randomized trial</article-title>. <source>Lung Cancer</source>. (<year>2001</year>) <volume>31</volume>(<issue>2-3</issue>):<fpage>277</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-5002(00)00194-X</pub-id><pub-id pub-id-type="pmid">11165408</pub-id></mixed-citation></ref>
<ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodjaev</surname> <given-names>S</given-names></name> <name><surname>Le</surname> <given-names>MD</given-names></name> <name><surname>Rao</surname> <given-names>W</given-names></name> <name><surname>Morelli</surname> <given-names>R</given-names></name></person-group>. <article-title>Retrospective evaluation of novel percutaneous left atrial appendage ligation using the LARIAT suturing device: single center initial experience</article-title>. <source>J Atr Fibrillation</source>. (<year>2014</year>) <volume>7</volume>(<issue>2</issue>):<fpage>1106</fpage>.<pub-id pub-id-type="pmid">27957103</pub-id></mixed-citation></ref>
<ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincenti</surname> <given-names>A</given-names></name> <name><surname>Genovesi</surname> <given-names>S</given-names></name> <name><surname>Sonaglioni</surname> <given-names>A</given-names></name> <name><surname>Binda</surname> <given-names>G</given-names></name> <name><surname>Rigamonti</surname> <given-names>E</given-names></name> <name><surname>Lombardo</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Mechanical atrial recovery after cardioversion in persistent atrial fibrillation evaluated by bidimensional speckle tracking echocardiography</article-title>. <source>J Cardiovasc Med (Hagerstown)</source>. (<year>2019</year>) <volume>20</volume>(<issue>11</issue>):<fpage>745</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.2459/JCM.0000000000000864</pub-id><pub-id pub-id-type="pmid">31483328</pub-id></mixed-citation></ref>
<ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x00E4;fer</surname> <given-names>M</given-names></name> <name><surname>Contreras</surname> <given-names>N</given-names></name> <name><surname>Ramakrishna</surname> <given-names>S</given-names></name> <name><surname>Zimmerman</surname> <given-names>JM</given-names></name> <name><surname>Varghese</surname><given-names>TK</given-names><suffix>Jr</suffix></name> <name><surname>Mitzman</surname> <given-names>B</given-names></name></person-group>. <article-title>Pre-Operative atrial deformation indices predict post-operative atrial fibrillation in patients undergoing lung resection surgery</article-title>. <source>Echocardiography</source>. (<year>2025</year>) <volume>42</volume>(<issue>2</issue>):<fpage>e70105</fpage>. <pub-id pub-id-type="doi">10.1111/echo.70105</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/798804/overview">Rohit Moudgil</ext-link>, Cleveland Clinic, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1469993/overview">Valentina Scheggi</ext-link>, Careggi University Hospital, Italy</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1401954/overview">Andrea Sonaglioni</ext-link>, IRCCS MultiMedica, Italy</p></fn>
</fn-group>
</back>
</article>